Parallel Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23K | Sell |
135
-553
| -80% | -$17.3K | ﹤0.01% | 2774 |
|
|
2025
Q1 | $23.1K | Buy |
688
+222
| +48% | +$7.45K | ﹤0.01% | 2054 |
|
|
2024
Q4 | $18.3K | Buy |
466
+85
| +22% | +$3.33K | ﹤0.01% | 2163 |
|
|
2024
Q3 | $15K | Sell |
381
-776
| -67% | -$30.6K | ﹤0.01% | 2220 |
|
|
2024
Q2 | $45.1K | Hold |
1,157
| – | – | ﹤0.01% | 1573 |
|
|
2024
Q1 | $49.8K | Buy |
1,157
+32
| +3% | +$1.38K | ﹤0.01% | 1500 |
|
|
2023
Q4 | $51.8K | Buy |
1,125
+381
| +51% | +$17.5K | ﹤0.01% | 1416 |
|
|
2023
Q3 | $25.4K | Sell |
744
-32
| -4% | -$1.09K | ﹤0.01% | 1715 |
|
|
2023
Q2 | $29.9K | Buy |
+776
| New | +$29.9K | ﹤0.01% | 1657 |
|